You need to tune into your body and listen to its cues
Hunt B, Malkin SJP, Moes RGJ, Huisman EL, Vandebrouck T, Wolffenbuttel BHR
Oral semaglutide has an advantage over oral insulin in that a fixed dosage can be safely administered with minimal hypoglycemic risk
Key Takeaways Early intervention with anti-obesity medications can transform outcomes for patients who dont respond well to initial treatments, offering hope and practical solutions for those struggling with conventional approaches
A November 2025 study found that GLP-1 receptor antagonist (RA) use, including semaglutide, was associated with reduced rates of urinary retention and urinary tract infections (UTIs) in non-diabetic women receiving treatment for overactive bladder syndrome
Key Points Semaglutide causes diarrhea through multiple mechanisms slowing stomach emptying while speeding up colon activity and affecting nutrient absorption Higher semaglutide doses used for weight loss (Wegovy) cause more GI issues than diabetes doses (Ozempic) Most people see improvement over time as their body adapts to the medication The diarrhea doesn't mean the drug is "working better" Starting semaglutide (Ozempic or Wegovy) can be an exciting development in your diabetes or weight loss journey